Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
0.9500
-0.0390 (-3.94%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Citius Pharmaceuticals Employees
Citius Pharmaceuticals had 23 employees as of September 30, 2024. The number of employees increased by 1 or 4.55% compared to the previous year.
Employees
23
Change (1Y)
1
Growth (1Y)
4.55%
Revenue / Employee
n/a
Profits / Employee
-$1,770,574
Market Cap
8.32M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
CTXR News
- 17 days ago - Citius Pharmaceuticals Announces $2 Million Registered Direct Offering of Common Stock - PRNewsWire
- 2 months ago - Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update - PRNewsWire
- 2 months ago - Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services - PRNewsWire
- 3 months ago - Citius Pharmaceuticals Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules - PRNewsWire
- 3 months ago - Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025 - PRNewsWire
- 3 months ago - Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives - PRNewsWire
- 4 months ago - Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update - PRNewsWire
- 5 months ago - Citius Pharmaceuticals Reports Productive FDA Type C Meeting to Discuss Phase 3 Mino-Lok® Program and Pathway to Approval - PRNewsWire